Genmab A/S Says Baillie Gifford & Co Held The Voting Rights To 3,301,530 Shares In Genmab A/S, Which Amounts To 4.99% Of The Share Capital And Voting Rights As Of October 3, 2024
Genmab A/S Says Baillie Gifford & Co Held The Voting Rights To 3,301,530 Shares In Genmab A/S, Which Amounts To 4.99% Of The Share Capital And Voting Rights As Of October 3, 2024
Genmab A/S表示，截至2024年10月3日，Baillie Gifford & Co持有Genmab A/S 3,301,530股股份的表決權，佔Genmab A/S股本和表決權的4.99%。
-
Major shareholder announcement for Genmab A/S
- genmab A/S的主要股東公告
COPENHAGEN, Denmark; October 4, 2024 – Genmab A/S (NASDAQ:GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Baillie Gifford & Co has informed us that, as of October 3, 2024, Baillie Gifford & Co held the voting rights to 3,301,530 shares in Genmab A/S, which amounts to 4.99% of the share capital and voting rights in Genmab A/S.
哥本哈根，丹麥; 2024年10月4日 - genmab A/S (納斯達克:GMAB)根據丹麥資本市場法第30條的規定宣佈，Baillie Gifford & Co已通知我們，截至2024年10月3日，Baillie Gifford & Co持有genmab A/S的3,301,530股表決權，佔genmab A/S的股本和表決權的4.99%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間